102
Views
2
CrossRef citations to date
0
Altmetric
Case Report

A Case Report of Cerebral Meningitis Caused by Penicillin-Non-Susceptible Group B Streptococcus in an Immunocompromised Adult Patient

, , &
Pages 2155-2160 | Published online: 06 Jul 2020

References

  • Lancefield RC. A serological differentiation of human and other groups of hemolytic streptococci. J Exp Med. 1933;57(4):571–595. doi:10.1084/jem.57.4.57119870148
  • Crespo-Ortiz Mdel P, Castañeda-Ramirez CR, Recalde-Bolaños M, Vélez-Londoño JD. Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study. BMC Infect Dis. 2014;14:428. doi:10.1186/1471-2334-14-42825086463
  • Farley MM. Group B streptococcal disease in nonpregnant adults. Clin Infect Dis. 2001;33(4):556–561. doi:10.1086/32269611462195
  • Sendi P, Johansson L, Norrby-Teglund A. Invasive group B Streptococcal disease in non-pregnant adults: a review with emphasis on skin and soft-tissue infections. Infection. 2008;36(2):100–111. doi:10.1007/s15010-007-7251-018193384
  • Bijlsma MW, Brouwer MC, Kasanmoentalib ES. Community-acquired bacterial meningitis in adults in the Netherlands:2006-14: a prospective cohort study. Lancet Infect Dis. 2016;16(3):339–347. doi:10.1016/S1473-3099(15)00430-226652862
  • van Kassel MN, van Haeringen KJ, Brouwer MC, Bijlsma MW, Diedrick VDB. Community-acquired group B streptococcal meningitis in adults: 33 cases from prospective cohort studies. J Infect. 2020;80(3):255–260. doi:10.1016/j.jinf.2019.12.00231830496
  • Sakata H, Sato Y, Nonoyama M, et al. Results of a multicenter survey of diagnosis and treatment for bacterial meningitis in Japan. J Infect Chemother. 2010;16(6):396–406. doi:10.1007/s10156-010-0064-620532942
  • Kimura K, Suzuki S, Wachino J, et al. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother. 2008;52(8):2890–2897. doi:10.1128/AAC.00185-0818490507
  • Dahesh S, Hensler ME, Van Sorge NM, et al. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother. 2008;52(8):2915–2918. doi:10.1128/AAC.00461-0818541727
  • Longtin J, Vermeiren C, Shahinas D, et al. Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy. Antimicrob Agents Chemother. 2011;55(6):2983–2985. doi:10.1128/AAC.01243-1021383092
  • Cooper K, Abbott F, Gould IM. Reduced penicillin susceptibility of group B Streptococcus: an assessment of emergence in Grampian, Scotland. Br J Biomed Sci. 2016;73:25–27. doi:10.1080/09674845.2016.114455027182673
  • van der Linden M, Mamede R, Levina N, et al. Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany. J Antimicrob Chemother. 2020;75(2):296–299. doi:10.1093/jac/dkz46531740946
  • Seki T, Kimura K, Reid ME, et al. High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan. J Antimicrob Chemother. 2015;70(10):2725–2728. doi:10.1093/jac/dkv20326169560
  • Kitamura M, Kimura K, Ido A, et al. Relatively high rates of cefotaxime- and ceftriaxone-non-susceptible isolates among group B streptococci with reduced penicillin susceptibility (PRGBS) in Japan. J Antimicrob Chemother. 2019;74(4):931–934. doi:10.1093/jac/dky54230649407
  • Chu YW, Tse C, Tsang GK, So DK, Fung JT, Lo JY. Invasive group B Streptococcus isolates showing reduced susceptibility to penicillin in Hong Kong. J Antimicrob Chemother. 2007;60(6):1407–1409. doi:10.1093/jac/dkm39017959733
  • Gaudreau C, Lecours R, Ismaïl J, Gagnon S, Jetté L, Roger M. Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone. J Antimicrob Chemother. 2010;65(3):594–595. doi:10.1093/jac/dkp45820022939
  • Matsubara K, Yamamoto G. Invasive group B streptococcal infections in a tertiary care hospital between 1998 and 2007 in Japan. Int J Infect Dis. 2009;13(6):679–684. doi:10.1016/j.ijid.2008.10.00719131262
  • Pimentel BA, Martins CA, Mendonça JC, et al. Streptococcus agalactiae infection in cancer patients: a five-year study. Eur J Clin Microbiol Infect Dis. 2016;35(6):927–933. doi:10.1007/s10096-016-2617-926993288
  • Smith EM, Khan MA, Reingold A, Watt JP. Group B streptococcus infections of soft tissue and bone in California adults:1995-2012. Epidemiol Infect. 2015;143(15):3343–3450. doi:10.1017/S095026881500060626418351
  • van Kassel MN, Bijlsma MW, Brouwer MC, van der Ende A, van de Beek D. Community-acquired group B streptococcal meningitis in adults: 33 cases from prospective cohort studies. J Infect. 2019;78(1):54–57. doi:10.1016/j.jinf.2018.07.00930063913
  • Rodrigo MD, ed. Treatment of Bacterial Meningitis Caused by Specific Pathogens in Adults. Waltham, MA: UpToDate Inc Available from: https://www.uptodate.com. Accessed 210 2020.
  • Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015;6:CD004405.
  • Morozumi M, Wajima T, Takata M, Iwata S, Ubukata K. Molecular characteristics of group B streptococci isolated from adults with invasive infections in Japan. J Clin Microbiol. 2016;54(11):2695–2700. doi:10.1128/JCM.01183-1627558182
  • Gudjónsdóttir MJ, Hentz E, Berg S, et al. Serotypes of group B streptococci in western Sweden and comparison with serotypes in two previous studies starting from 1988. BMC Infect Dis. 2015;15(1):507. doi:10.1186/s12879-015-1266-426553333
  • Salloum M, van der Mee-marquet N, Valentin-Domelier AS, Quentin R. Diversity of prophage DNA regions of Streptococcus agalactiae clonal lineages from adults and neonates with invasive infectious disease. PLoS One. 2011;6(5):e20256. doi:10.1371/journal.pone.002025621633509
  • Wong SS, Tsui K, Liu QD, et al. Serotypes, surface proteins, and clinical syndromes of invasive Group B streptococcal infections in northern Taiwan:1998-2009. J Microbiol Immunol Infect. 2011;44(1):8–14. doi:10.1016/j.jmii.2011.01.00321531346
  • Lartigue MF, Héry-Arnaud G, Haguenoer E, et al. Identification of Streptococcus agalactiae isolates from various phylogenetic lineages by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2019;47(7):2284–2287. doi:10.1128/JCM.00175-09
  • Ka-Ning T, Cornwell E, Daniel R, et al. Evaluation of Matrix-Assisted Laser Desorption Ionisation Time-Of-Flight Mass Spectrometry (MALDI-TOF MS) for the identification of Group B Streptococcus. BMC Res Notes. 2019;12(1):85. doi:10.1186/s13104-019-4119-130764872
  • Binghuai L, Yanli S, Shuchen Z, Fengxia Z, Dong L, Yanchao C. Use of MALDI-TOF Mass Spectrometry for Rapid Identification of Group B Streptococcus on chromID Strepto B Agar. Int J Infect Dis. 2014;27:44–48. doi:10.1016/j.ijid.2014.06.02325220051
  • Lartigue MF, Kostrzewa M, Salloum M, et al. Rapid detection of “highly virulent” Group B Streptococcus ST-17 and Emerging ST-1 Clones by MALDI-TOF mass spectrometry. J Microbial Methods. 2011;86(2):262–265. doi:10.1016/j.mimet.2011.05.017
  • Alatoom AA, Cunningham SA, Ihde SM, Mandrekar J, Patel R. Comparison of direct colony method versus extraction method for identification of gram-positive cocci by use of bruker biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Mirobiol. 2011;49(8):2868–2873. doi:10.1128/JCM.00506-11
  • Metcalf BJ, Chochua S, RE G Jr, et al. Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive streptococcus agalactiae recovered in the USA. Clin Microbial Infect. 2017;23(8):574. doi:10.1016/j.cmi.2017.02.021
  • Tsai MH, Hsu JF, Lai MY, et al. Molecular characteristics and antimicrobial resistance of Group B streptococcus strains causing invasive disease in neonates and adults. Front Microbiol. 2019;18:264. doi:10.3389/fmicb.2019.00264
  • Kimura K, Nagano N, Nagano Y, et al. High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility. J Antimicrob Chemother. 2013;68(3):539–542. doi:10.1093/jac/dks42323111853